Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
9.09
-0.01 (-0.11%)
At close: Nov 13, 2024, 4:00 PM
9.05
-0.04 (-0.44%)
After-hours: Nov 13, 2024, 4:23 PM EST
Grifols Market Cap
Grifols has a market cap or net worth of $7.26 billion as of November 13, 2024. Its market cap has increased by 34.40% in one year.
Market Cap
7.26B
Enterprise Value
19.63B
1-Year Change
34.40%
Ranking
Category
Stock Price
$9.09
Market Cap Chart
Since June 2, 2011, Grifols's market cap has increased from $5.00B to $7.26B, an increase of 45.37%. That is a compound annual growth rate of 2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2024 | 6.26B | -21.28% |
| Dec 29, 2023 | 7.95B | 36.00% |
| Dec 30, 2022 | 5.84B | -24.31% |
| Dec 31, 2021 | 7.72B | -39.10% |
| Dec 31, 2020 | 12.68B | -20.82% |
| Dec 31, 2019 | 16.01B | 26.85% |
| Dec 31, 2018 | 12.62B | -19.90% |
| Dec 29, 2017 | 15.76B | 42.63% |
| Dec 30, 2016 | 11.05B | -0.80% |
| Dec 31, 2015 | 11.14B | -4.68% |
| Dec 31, 2014 | 11.69B | -0.94% |
| Dec 31, 2013 | 11.80B | 39.30% |
| Dec 31, 2012 | 8.47B | 134.45% |
| Dec 30, 2011 | 3.61B | -27.71% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Walgreens Boots Alliance | 7.89B |
| Jazz Pharmaceuticals | 7.74B |
| Ascendis Pharma | 7.65B |
| Halozyme Therapeutics | 7.47B |
| Legend Biotech | 7.46B |
| Elanco Animal Health | 7.03B |
| Madrigal Pharmaceuticals | 7.01B |
| Bausch + Lomb | 6.94B |